Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
132M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
26.2M
-
Shares change
-
-336K
-
Total reported value, excl. options
-
$774M
-
Value change
-
-$11.9M
-
Put/Call ratio
-
0.61
-
Number of buys
-
68
-
Number of sells
-
-45
-
Price
-
$31.05
Significant Holders of RAPT Therapeutics, Inc. - Common Stock (RAPT) as of Q3 2021
147 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock as of Q3 2021.
RAPT Therapeutics, Inc. - Common Stock (RAPT) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.2M shares
of 132M outstanding shares and own 19.87% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (3.9M shares), PERCEPTIVE ADVISORS LLC (2.91M shares), BlackRock Inc. (1.9M shares), Ponoi Management, LLC (1.6M shares), WELLINGTON MANAGEMENT GROUP LLP (1.51M shares), Column Group LLC (1.4M shares), KPCB XV Associates, LLC (1.3M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1.15M shares), FMR LLC (1.14M shares), and VANGUARD GROUP INC (1.08M shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.